| 23:30 - 00:15 | Oral Abstracts Session: Kidney Transplantation: Biomarkers |
| 210.1 |
Diagnostic tests for delayed graft function: A systematic review Christina Lai, Australia |
| 210.2 |
Integrative analysis of prognostic biomarkers for acute rejection in kidney transplant recipients Yue Cao, Australia |
| 210.3 |
Assessment of the usefulness of acute rejection specific transcriptomic signatures in a prospective kidney transplantation cohort Su Woong Jung, Korea |
| 210.4 |
The clinical utility of preformed C1q-binding donor-specific HLA antibodies in kidney transplantation Sua Lee, Korea |
| 23:30 - 00:15 | Oral Abstracts Session: Innate and Adaptive Immunity |
| 211.1 |
Gasdermin-D mutation is protective against renal ischemia reperfusion injury Jennifer Li, Australia |
| 211.5 (P-2.74 in Journal) |
Oral administration of nano-sized silicon particles attenuates oxidative stress and ischemia-reperfusion injury in a rat model: A novel hydrogen administration method Masataka Kawamura, Japan |
| 211.3 |
Modulation of the IL-33/ST2 axis for regulatory T cell therapy in transplantation Kento Kawai, United Kingdom |
| 211.4 |
Development of fully differentiated pancreatic organoids from hiPSCs for type 1 diabetes cell therapy Giuseppe Pettinato, United States |
| 00:15 - 02:00 | State-of-the-Art Session: Tissue-Resident Lymphocytes |
| 220.1 |
Formation and plasticity of tissue resident memory populations in human allografts revealed by single cell analysis and serial TCR sequencing Megan Sykes, United States |
| 220.2 |
Antigen presentation by tissue resident APC Adrian E. Morelli, United States |
| 220.3 |
Reshaping T cell memory with lymphoablation Anna Valujskikh, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Immune Regulation and Outcomes |
| 251.2 |
Discovery of pMHC epitopes for directly alloreactive T cells Eric Taeyoung ES Son, Australia |
| 251.3 |
The Prediction of Kidney Allograft Acute Rejection Based on Recipient Peripheral Blood Whole Transcriptome Profiling and Three mRNA Molecular Signatures Liao Minxue, People's Republic of China |
| 251.1 |
Elucidating the role of hypoxia in regulatory T cell function Marie Sion, United Kingdom |
| 08:15 - 10:00 | State-of-the-Art Session: Banff 2019 Update for Allograft Rejection |
| 262.1 |
Liver (morphology) Andrew Clouston, Australia |
| 262.4 |
Kidney (molecular) Carmen Lefaucheur, France |
| 262.3 |
Kidney (morphology) Hyeon Joo Jeong, Korea |
| 262.2 |
Liver (molecular phenotyping) Alberto Sanchez-Fueyo, United Kingdom |
| 14:30 - 15:15 | Oral Abstracts Session: Biomarkers and Omics |
| 281.3 |
Single cell transcriptomic analysis for a better understanding of human CD8+ regulatory T cells Céline Serazin, France |
| 281.1 |
Transplantation of older organs transfers senescence Jasper Iske, Germany |
| 281.5 (P-2.125 in Journal) |
TCR repertoire sequencing of total T cells and circulating follicular helper T cells in kidney transplant recipients Patricia Almendro Vázquez, Spain |
| 281.2 |
Diagnosis of kidney transplant rejection by tracking donor-reactive T-cell clones in the post-transplant biopsy, blood and urine samples Joseph R. Leventhal, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Kidney Transplantation: The borg and beyond |
| 290.1 |
The repair shop: Our current opportunities in improving the quality of kidneys Sarah Hosgood, United Kingdom |
| 290.2 |
A reality check - kidney organoids: What to expect in the next 10 years Benjamin Humphreys, United States |
| 290.3 |
Artificial intelligence in renal transplantation: core concepts, examples, limits and perspectives Olivier Niel, Luxembourg |
| 15:15 - 17:00 | State-of-the-Art Session: Social Media for Scientists |
| 291.3 |
Impact of social media on research dissemination Carla C. Baan, Netherlands |
| 291.1 |
Introduction and creating networks Frank JMF Dor, United Kingdom |
| 291.2 |
Healthcare and patient education Macey L. Henderson, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Kidney Transplantation: Predicting allograft survival |
| 310.4 |
A personalised prediction model for allograft survival after kidney transplantation Yunwei Zhang, Australia |
| 310.2 |
Simultaneously detection of ddcfDNA in plasma and urine assist to determine the type of rejection in renal transplant patients Dongrui Cheng, People's Republic of China |
| 310.1 |
Advanced tertiary lymphoid tissues in protocol biopsies predict progressive graft dysfunction in kidney transplant recipients Yu Ho Lee, Korea |
| 310.3 |
Near-single-cell proteomicsprofiling of the proximal tubular and glomerulus of the normal human kidney Tara Sigdel, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Histocompatibility and Cancer Complications |
| 314.1 |
Do we predict mismatches that induce de novo DSA or do we predict the ones that do not? Vadim Jucaud, United States |
| 314.2 |
HLA molecular mismatch analysis in patients receiving kidney and the hematopoietic stem / facilitating cell induction protocol Anat Tambur, United States |
| 314.3 |
Cancer risk in solid organ transplant recipients: A systematic review and meta-analysis Zhenyu Huo, People's Republic of China |
| 314.5 (P-11.126 in Journal) |
Relative survival in kidney transplant recipients with de-novo cancers vs non-transplant cancer patients: A population study 1980-2016 Nicole Louise De La Mata, Australia |
| 07:30 - 08:15 | Oral Abstracts Session: Kidney Transplantation: Ischemia/reperfusion injury and long-term graft outcomes |
| 350.1 |
Role of IL-6 and IL-17 mediated inflammation amplifier loop in Chronic Antibody-Mediated Rejection (CABMR) Mantabya Kumar Singh, India |
| 350.2 |
A biocompatible nanoparticle-based approach to inhibiting renal ischemia reperfusion injury in mice by blocking thrombospondin-1 activity Tianmeng Sun, People's Republic of China |
| 350.4 |
Impact of acute kidney injury on graft outcomes in deceased donor kidney transplantation: A nationwide registry-based matched cohort study in Korea Jane Ha, Korea |
| 350.5 (P-2.81 in Journal) |
A point mutation of SHROOM3 promotes CD206+ macrophage infiltration and kidney fibrosis after ischemia-reperfusion injury Tianfeng Tang, People's Republic of China |
| 08:15 - 10:00 | State-of-the-Art Session: The Future is Now… Immune Regulation in Transplantation |
| 360.1 |
The Regulation of Immune Tolerance by FOXP3 - basic Ling Lu, People's Republic of China |
| 360.2 |
Intragraft immune regulation protects transplants under sub-therapeutic immunosuppression Paloma Riquelme, Germany |
| James Alexander Hutchinson, Germany |
| 360.3 |
Clinical experience of Treg therapy Fadi Issa, United Kingdom |
| 14:30 - 15:15 | Oral Abstracts Session: Kidney Transplantation: Antibody-mediated rejection and composite end points |
| 380.1 |
Anti-IL-6 antibody clazakizumab in late antibody-mediated rejection – Molecular rebound phenomena under IL-6 blockade? Anita Borski, Austria |
| 380.4 |
Analyzing causes for death-censored allograft failure in kidney transplant recipients Manuel Mayrdorfer, Germany |
| 380.2 |
Clazakizumab (Anti-IL-6 Monoclonal) treatment of patients with chronic & active antibody-mediated rejection post-kidney transplantation (NCT03380377) Stanley Jordan, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Immune Regulation and Tolerance I |
| 381.1 |
Treg use the PD-1-PD-L1 axis for lymphatic transendothelial migration Wenji Piao, United States |
| 381.2 |
Donor liver plasmacytoid dendritic cells promote effector T cell exhaustion and augment Treg responses in mouse spontaneous liver transplant tolerance Ryosuke Nakano, United States |
| 381.3 |
Lymph node stromal laminin alpha 5 regulates adaptive immunity Lushen Li, United States |
| 15:15 - 17:00 | State-of-the-Art Session: Novel Insights in Allorecognition |
| 391.3 |
Non-HLA allorecognition and graft loss Roman Reindl-Schwaighofer, Austria |
| 391.2 |
T-cell allorecognition Gavin Pettigrew, United Kingdom |
| 391.1 |
Innate allorecognition Fadi G. Lakkis, United States |
| 23:30 - 00:15 | Oral Abstracts Session: Kidney Transplantation: Novel approaches to monitoring |
| 410.1 (P-11.189 in the Journal) |
Reactivation of murine polyomavirus replication by renal ischemia-reperfusion injury and immunosuppression Gang Huang, People's Republic of China |
| 410.3 |
Analysis of the difference of the monitoring results of TCR high variable area in renal transplant recipients after treatment with different immune induction schemes Tian Puxun, People's Republic of China |
| 410.4 |
Novel human kidney cell subsets identified by Mux-Seq Tara Sigdel, United States |
| 07:30 - 08:15 | Oral Abstracts Session: Kidney Transplantation: Living donation and long-term follow-up |
| 450.2 (P-11.107 in Journal) |
Impact of single centre 440 kidney exchange transplantation over 20 years to increase living donor pool in India: A cohort study Harshit M Patel, India |
| 450.3 |
Telemedicine clinic for renal transplant patients during COVID-19 pandemic Fatima AlKindi, United Arab Emirates |
| 450.4 |
Parameters affecting estimated glomerular filtration rate and developing hypertension after donor nephrectomy Zeynep Kendi Çelebi, Turkey |
| 07:30 - 08:15 | Oral Abstracts Session: Immune Regulation and Tolerance II |
| 451.3 |
PD-L1 / PD-1 interactions are critical for tolerance induction in primed skin graft recipients following liver-directed MHC class I gene transfer Mario L Leong, Australia |
| 451.2 |
Identification and isolation of human HLADR+ CD27+ Treg as xeno-antigen Treg subset for xenotransplantation Xiaoqian Ma, People's Republic of China |
| 451.1 |
Transient antibody targeting of CD45RC to prevent the development of acute graft versus host diseases Carole Guillonneau, France |
| 451.4 |
CTLA-4-Ig prolongs graft survival specifically in young but not in old recipients Jasper Iske, Germany |
| 08:15 - 10:00 | State-of-the-Art Session: A Kidney for Life: A goal for all practitioners |
| 460.1 |
A look at the long-term surviving patient: What makes them so exceptional? Germaine Wong, Australia |
| 460.2 |
Chronic allograft injury: CAN CAN be fixed? Dirk R. J. Kuypers, Belgium |
| 460.3 |
Anti-body mediated rejection: Consensus on treatment? Roslyn B Mannon, United States |
| 14:30 - 15:15 | Oral Abstracts Session: Kidney Transplantation: Desensitization and other complications |
| 480.1 |
Clazakizumab® (Anti-IL-6) for desensitization of highly-HLA sensitized patients awaiting kidney transplant (NCT03380962) Ashley Vo, United States |
| 480.2 |
Clazakizumab (anti-IL-6) induces FoxP3+ Tregs in highly HLA sensitized patients receiving HLAi kidney transplantation (NCT03380962) Stanley Jordan, United States |
| 480.3 |
CD8+ T cell senescence is a distinct immunological state that identifies long-term renal transplant recipients at increased risk of future malignancy Matt J Bottomley DPhil, United Kingdom |
| 15:15 - 17:00 | State-of-the-Art Session: Sex as an Immunological Variable |
| 490.3 |
The role of the X chromosome in organ transplantation Anette Melk, Germany |
| 490.1 |
Improved renal ischemia tolerance in females influences kidney transplantation outcomes Matthew Levine, United States |
| 490.2 |
Sex as a biological variable Stefan G. Tullius, United States |
| Poster Session: Basic and Translational Sciences |
| P-2.02 |
B-cell depletion with anti-CD20 mAb exacerbates anti-donor CD4 positive T-Cell responses in highly sensitized transplant model Asuka Tanaka, Japan |
| P-2.03 |
Noninvasive genotyping of donor’s HLA in kidney transplant patients by target capture sequencing Liu Feng, People's Republic of China |
| P-2.04 |
Clinical significance of pretransplant donor-specific HLA antibodies in kidney transplant recipients of hispanic population Idalia Parra-Avila, Mexico |
| P-2.05 |
Female complexity: High ‘natural’ ABO anti-A antibodies and IgG class switch in female vs male mice Bushra Anjum, Canada |
| P-2.10 |
Immune reconstitution after autologous hematopoietic stem cell transplantation in multiple myeloma patients as a basis for early vaccination with T-cell dependent vaccines Igor Stoma, Belarus |
| P-2.11 |
Imbalance favouring follicular helper T cells over IL10+ regulatory B cells is detrimental for the renal allograft Alberto Utrero-Rico, Spain |
| P-2.13 |
Extracellular vesicles from urine as biomarkers of kidney allograft injury: optimization of extracellular vesicle isolation and characterization Ivana Sedej, Slovenia |
| P-2.14 |
Establishment of early warning model of acute rejection in combination with HLA-G 14-bp gene polymorphism, serum KIM-1and OPN Zhankui Jin, People's Republic of China |
| P-2.15 |
Immunosuppression affects circulating follicular regulatory T cells in kidney transplant recipients Carla C. Baan, Netherlands |
| P-2.16 |
The use of dd-cfDNA as a predictive tool for future proteinuria Thierry Viard, United States |
| P-2.17 |
Characterization of an integrative prognostic score for US patients taken from the DART study Thierry Viard, United States |
| P-2.18 |
dd-cfDNA as a risk factor for initiating de-novo donor specific antibodies in heart transplantation Thierry Viard, United States |
| P-2.19 |
Factors influencing background cell-free DNA levels: Implications for donor derived cell-free DNA assessment in transplant patients Trudy McKanna, United States |
| P-2.20 |
Anti-rejection therapy does not eliminate donor-reactive IFN-γ and IL-21 producing cells Nicole M. van Besouw, Netherlands |
| P-2.22 |
Use of dd-cfDNA as a surrogate marker of injury following hypothermic machine perfusion Thierry Viard, United States |
| P-2.23 |
Establishment of early diagnostic model of acute rejection in combination with IL-2, IL-6, TNF-α and IFN-γ Zhankui Jin, People's Republic of China |
| P-2.24 |
Incidence and risk factors of new onset diabetes after solid organ transplantation: Baskent University experience Didem Turgut, Turkey |
| P-2.25 |
Value of dd-cfDNA when considering recipient ethnicity to further to help risk stratify transplant recipients Thierry Viard, United States |
| P-2.26 |
Long-lasting effects of anti-rejection therapy on natural antibodies and alloreactive T cells in kidney transplant patients Nicole M. van Besouw, Netherlands |
| P-2.27 |
Podocyte-specific urinary extracellular vesicles: A novel biomarker for recurrent primary focal segmental glomerulosclerosis after kidney transplantation Hien Lau, United States |
| P-2.29 |
The relationship between myocardial fibrosis and plasma level of galectin-3 in heart transplant recipients underwent acute rejection Rivada Kurabekova, Russian Federation |
| P-2.30 |
Do the blood groups and HLA types have a role in end stage chronic renal failure pathogenesis? A comparative retrospective single-center study Ugur Musabak, Turkey |
| P-2.31 |
Immune signs of accommodation in kidney transplant recipients Maciej Zieliński, Poland |
| P-2.33 |
The utility of QuantiFERON monitoring based assay in assessing clinical events among kidney transplant recipients Maisarah Jalalonmuhali, Malaysia |
| P-2.37 |
IL-21 as a new target for immunosuppressive therapies Carla C. Baan, Netherlands |
| P-2.38 |
The small-molecule BCL6-inhibitor 79-6 suppresses follicular T helper cell differentiation and plasma blast formation Rens Kraaijeveld, Netherlands |
| P-2.39 |
Intra-lymph node delivery of macroparticles loaded with rapamycin in non-human primates Zahra Habibabady, United States |
| P-2.40 |
Clinical-experimental experience with rapamycin in visceral transplantation Javier Serradilla, Spain |
| P-2.41 |
The effects of a novel drug, PQA 18, on small intestinal transplantation Tasuku Kodama, Japan |
| P-2.45 |
Cyclic helix B peptide ameliorates renal fibrosis induced by unilateral ureter obstruction via inhibiting NLRP3 pathway Cheng Yang, People's Republic of China |
| P-2.47 |
The preventive effect of sirolimus on ureteral stricture formation Sanem Cimen, Turkey |
| P-2.49 |
Primate tolerance model demonstrates longer kidney graft survival with the administration of polyclonal ex-vivo expanded Tregs Karina Bruestle, United States |
| P-2.50 |
IL-4 regulates the secretion of IL-10 by human B cells Griffith Perkins, Australia |
| P-2.51 |
Immunomodulation with SA-PDL1 protein on pancreatic islets promotes indefinite graft survival in allogeneic recipients Esma ESY Yolcu, United States |
| P-2.53 |
Anti-IL-6 antibody reduces endothelial mediated pro-inflammatory responses and after binding of HLA-specific DSA to endothelial cells Nuala Mooney, France |
| P-2.54 |
Preclinical study for tolerance induction to liver allografts with rapid immunosuppression withdrawal in Cynomolgus monkeys Hiroshi Sakai, United States |
| P-2.55 |
Strong engagement of Cd137 suppresses graft-versus-host disease through dendritic cells Sang Jun Park, Korea |
| P-2.59 |
The requirement of thymic irradiation for induction of mixed chimerism and renal allograft tolerance in non-human primates Takayuki Hirose, United States |
| P-2.60 |
Experimental evidence on the role of the spleen in graft versus host disease after visceral transplantation Pablo Stringa, Argentina |
| P-2.62 |
Advantages of rhesus macaques in a tolerance model for combined bone marrow and kidney transplantation Karina Bruestle, United States |
| P-2.63 |
siRNA gene knockdown with functionalised porous silicon nanoparticles Sebastian O Stead, Australia |
| P-2.66 |
Class II HLA eplet mismatch is related to anti-donor CD4+ T cell response and de novo donor-specific antibody development in kidney transplantation recipient Hiroaki Yamane, Japan |
| P-2.70 |
Changes in phenotype of human CD4+CD25+CD127lo Treg subpopulations after culture with rIL-2 and alloantigen Nirupama D Verma, Australia |
| P-2.73 |
Mobilization of mast cells and regulatory t-cells by tetrahydrobiopterin is associated with prolonged allograft survival Manuel Maglione, Austria |
| P-2.82 |
INT 767 – A novel dual farnesoid-X receptor (FXR) and takeda G-protein-coupled receptor-5 (TGR5) agonist attenuates intestinal ischemia reperfusion injury Emilio Canovai, Belgium |
| P-2.84 |
High-mobility group box 1 protein antagonizes the immunosuppressive capacity and therapeutic effect of mesenchymal stem cells in acute kidney injury Cheng Yang, People's Republic of China |
| P-2.85 |
Mesenchymal stem cell-derived exosomes suppress of NLRP3 inflammasome activation to enhance anti-anoxic ability of porcine islets Wei Nie, People's Republic of China |
| P-2.95 |
A novel rodent model of severe renal ischemia reperfusion injury that better mimics the renal transplant recipient Ryan Ghita, United Kingdom |
| P-2.96 |
Ischemic preconditioning ameliorates renal ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy in mice Jeongkye Hwang, Korea |
| P-2.99 |
In-depth assessment of ischemia/reperfusion injury in a murine model of hindlimb transplantation Franka Messner, Austria |
| P-2.103 |
Ischemic preconditioning attenuates renal ischemia-reperfusion injury by TLR4 suppression and eNOS activation Jeongkye Hwang, Korea |
| P-2.104 |
The impact of oxygen free radical scavenger on acute rejection in a histocompatible miniature swine model Philipp Tratnig-Frankl, United States |
| P-2.105 |
The tissue Common Response Module (tCRM) score provides a quantitative objective biopsy score to assess the severity of pancreas transplant rejection Yvonne Kelly, United States |
| P-2.107 |
Increased level of serum cholesterol and apoptosis together induces the development of liver fibrosis and early allograft loss Binnaz Handan Ozdemir, Turkey |
| P-2.108 |
Analyzing interactions between donor endothelium and recipient blood under flow conditions in vitro Margaret Connolly, United States |
| P-2.113 |
Influence of β-Catenin on the proliferation of vascular smooth muscle cells and the development of cardiac allograft vasculopathy in mice Christian Heim, Germany |
| P-2.115 |
Recipient bone marrow Treg; major players in transplant tolerance Amy Prosser, Australia |
| P-2.116 |
High-fibre diet reduces transplant-associated dysbiosis and improves renal allograft survival in a murine model of kidney allograft rejection Julian Singer, Australia |
| P-2.119 |
Gut microbiome dynamics over a course of kidney transplantation: Preliminary results of a pilot study Igor Stoma, Belarus |
| P-2.121 |
Characterization of donor and recipient myeloid cells following congenic and allogeneic liver transplantation Sarah J Dart, Australia |
| P-2.122 |
Preparation of transplantable acellular scleral graft using porcine eye Kyungmee Park, Korea |
| P-2.123 |
Preparation of ultra-thin descemet's membrane graft using decellularized porcine cornea Kyungmee Park, Korea |
| P-2.124 |
NK cell exhaustion facilitates tumor recurrence after liver transplantation via the TLR4 / HLA-E signaling pathway Xinxiang Yang, People's Republic of China |
| P-2.126 |
Assessment of HLA typing performance of Korea Biobank Array for transplantation genome-wide association study in Koreans Young Jin Kim, Korea |
| P-2.129 |
A genome-wide association study identified genetic loci for end-stage renal disease in the Korean population Young Jin Kim, Korea |
| P-2.130 |
Vascular endothelial growth factor (vegf) 936 C/T gene polymorphism in renal transplant recipients: Association with graft rejection and final graft outcome Manzoor Parry, India |
| P-2.131 |
Lymphotoxin beta receptor regulates Treg stability, migration, and function Vikas Saxena, United States |
| P-2.133 |
Liver tissue-resident lymphocytes are significantly heterogeneous, and the original repertoire is not recreated by infiltrating recipient cells Amy Prosser, Australia |
| P-2.137 |
Ischemic and perfused kidney treated with non-cultured adipose-derived regenerative cells increase the immune and regulatory transcriptome Ryan Ghita, United Kingdom |
| Poster Session: Histocompatibility |
| P-7.07 |
Assessment of ABO-histocompatibility: Modernizing ABO antibody detection tools for use in transplantation Anne Halpin, Canada |
| P-7.10 |
Can epitope matching outmatch traditional HLA matching? Christian Unterrainer, Germany |
| P-7.04 |
Prospective de novo DSA monitoring in renal transplant patients Efstratios Kasimatis, Greece |
| P-7.05 |
Angiotensin II Type 1 Receptor Antibodies: Risk for rejection and impaired graft function Angeliki G. Vittoraki, Greece |
| P-7.14 |
Tregs monitoring before and after renal transplantation Efstratios Kasimatis, Greece |
| P-7.06 |
Impact of delayed graft function on highly sensitized patients in deceased donor kidney transplantation Seong Gyu Kim, Korea |
| P-7.12 |
Evaluation of a novel ultra-high-resolution assay and analytic software for next generation sequencing based genotyping of 11 human leukocyte antigen loci MIMI JANG, Korea |
| P-7.02 |
Medium to long term impact of pre transplant DSA on allograft outcomes in deceased donors transplants Muhammad A Khurram, United Kingdom |
| P-7.08 |
Impact of induction regimen, human leukocyte antigen mismatches and steroid maintenance on recipient and graft survival with different glomerulonephridities Samy M Riad, United States |
| Poster Session: Kidney |
| P-11.05 |
Individualized preconditioning for ABO incompatible living donor kidney transplantation: An initial report of 48 cases from China Xianding Wang, People's Republic of China |
| P-11.06 |
Comparative study of ATG vs ATG-F (Grafalon) as an induction agent in ABO incompatible kidney transplantation Ravi Kumar Singh, India |
| P-11.13 |
Prophylactic treatment with antioxidant nanoparticles attenuate ischemia/reperfusion injury in BALB/c mice Se-Hee Yoon, Korea |
| P-11.14 |
Role of diltiazem in short-term outcome of live related renal transplant hypertensive recipients with non-surgical delayed graft function Shahzad Alam, India |
| P-11.15 |
Incidence, risk factors & patient outcomes of acute kidney injury in patients undergoing living donor liver transplant- A prospective single centre study Abhyudaysingh Rana, India |
| P-11.17 |
Outcomes of deceased donor kidney transplantation using kidneys from donors with acute kidney injury Kyeongdeok Kim, Korea |
| P-11.18 |
Tubulo-Interstitial Nephritis in Graft Kidney Transplant Post Azathioprine Introduction Salima Awadh Al alawi, Oman |
| P-11.19 |
Diabetes mellitus is a risk of AKI incidence in liver transplantation patients Yujia Wang, People's Republic of China |
| P-11.20 |
Cardiovascular outcomes of rapamycin-based immunosuppression in kidney transplant recipients: A single center retrospective study Sojung Yoon BE, Korea |
| P-11.23 |
Should be use kidneys of KDPI higher than 85 percentage for older recipients? Maria del Carmen Rial, Argentina |
| P-11.26 |
The current status and predictors of exercise in kidney transplant recipients: A prospective study using the Health Action Process Approach shujing hu, Hong Kong |
| P-11.33 |
Detection of donor-derived cell-free DNA: Non-invasive prediction of silent antibody-mediated rejection in donor-specific antibody-positive renal allograft recipients Markus Wahrmann, Austria |
| P-11.35 |
Impact of low dose donor specific anti-HLA antibodies between living donor versus deceased donor kidney transplantation Seong Gyu Kim, Korea |
| P-11.36 |
Combined impact of pre-sensitization and delayed graft function on allograft rejection in deceased donor kidney transplantation: Nationwide cohort study Hanbi Lee, Korea |
| P-11.39 |
The influence of the donor kidney weight to recipient body weight on long-term renal graft outcomes Seok Jeong Yang, Korea |
| P-11.40 |
A proof of concept study for [18F]-sodium fluoride imaging of nephrocalcinosis in donor kidneys and explanted renal allografts Stan Benjamens, Netherlands |
| P-11.43 |
Urinary beta-2-microglobulin as a biomarker for chronic allograft injury and rapid renal function decline in kidney transplant recipients Hee Jung Jeon, Korea |
| P-11.47 |
Inferior outcomes of basiliximab compared to anti-thymocyte globulin induction therapy in kidney transplantation with weak pretransplant donor specific anti-HLA antibody Hyunmin Ko, Korea |
| P-11.52 |
Kidney transplantation from HBsAg+ living donors to HBsAg- recipients: Clinical outcomes at a high-volume center in China Xianding Wang, People's Republic of China |
| P-11.53 |
Cytomegaloviurs-Associated Hemophagocytic Syndrome Diagnosed by Liver Biopsy in a Kidney Transplant Recipient: A case report Eun Ji Choi, Korea |
| P-11.54 |
Lymphocyte subset test as a determinant of Cytomegalovirus prophylaxis in renal transplant recipients with anti-thymocyte globulin induction therapy Mihyeong Kim, Korea |
| P-11.55 |
Differential impact of allograft rejection on kidney transplant patients with BKV infection Ji Won Min, Korea |
| P-11.56 |
Changing severity of Dengue infection in renal transplant recipients: “Unpredictable and lethal” Harshit M Patel, India |
| P-11.59 |
Cytomegalovirus infection after kidney transplantation with pre-emptive strategy: A single-center retrospective cohort study Chumpol Santisiripat MD, Thailand |
| P-11.62 |
Urinary tract infections in renal transplant recipients in three years Cigdem Erol, Turkey |
| P-11.63 |
Pre-kidney transplant latent tuberculosis infection screening and posttransplant active tuberculosis Gisele Meinerz, Brazil |
| P-11.65 |
Emphysematous pyelonephritis in renal transplant recipient Marisa M Cobos, Argentina |
| P-11.68 |
Pre-transplant HLA antibodies and delayed graft function in the current era of kidney transplantation Caner Suesal, Germany |
| P-11.69 |
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation Tamar AJ van den Berg, Netherlands |
| P-11.70 |
Effect of cold, warm, and composite ischaemic times on one year graft function Christopher Seet, United Kingdom |
| P-11.72 |
CHAIR Score: A novel risk stratification in transplant renal artery stenosis Xiangyong Tian, People's Republic of China |
| P-11.75 |
Abdominal aorta calcification prior to kidney transplantation: The association with patient and graft survival Stan Benjamens, Netherlands |
| P-11.76 |
Review of efficacy and short term safety of sodium-glucose cotransporter 2 (SGLT2) inhibitors use in diabetic renal transplant recipients Fatima AlKindi, United Arab Emirates |
| P-11.78 |
Surgical complications after pediatric kidney transplantation Aydincan Akdur, Turkey |
| P-11.79 |
Co-infection CMV/BK in kidney transplant recipients Luis Roberto Leon, Argentina |
| P-11.80 |
The efficacy of low-dose aspirin in preventing transplant renal artery stenosis (TRAS): A single-center study Xiangyong Tian, People's Republic of China |
| P-11.81 |
Using the Clavien-Dindo classification to identify risk factors in kidney transplantation Christopher Seet, United Kingdom |
| P-11.83 |
Risk factors of recurrence of vesicoureteral reflux after endoscopic treatment after kidney transplantation Pai Yen Pan, Taiwan |
| P-11.84 |
Beware the band adhesion: An unexpected cause of small bowel obstruction following intraperitoneal kidney transplantation David Tovmassian, Australia |
| P-11.86 |
Assessment of neuropathy among renal transplant recipients with post-transplant diabetes mellitus: Kuwait experience Osama Gheith, Kuwait |
| P-11.89 |
Is it possible to prevent reperfusion ischemic injury and DGF (delayed graft function) in kidney allograft? How? Afshar Zomorrodi, Iran (Islamic Republic of) |
| P-11.90 |
Timely surgical intervention for ureteric complications ensures adequate graft function in renal transplantation: A 10-year review Joseph S Jaya, Australia |
| P-11.92 |
Implementation of increased viral risk donor waiting list for pre-consented waitlisted recipients in Victoria, Australia Nina Seng, Australia |
| P-11.94 |
Retrospective analysis of the Kidney Donor Profile Index (KDPI) with patient and graft survival at 5 years post transplantation Nasly G Patino-Jaramillo MD, Colombia |
| P-11.96 |
Impact of donor cardiopulmonary resuscitation on long-term allograft outcome after deceased donor kidney transplantation in Thailand Thawin Srinutta, Thailand |
| P-11.101 |
The donor factors related with delayed graft function after deceased donor kidney transplantation Woo Yeong Park, Korea |
| P-11.102 |
Donor difference is an important factor to accelerate the implementation of enhanced recovery after surgery (ERAS) in renal transplantation Tian Puxun, People's Republic of China |
| P-11.103 |
Effect of recipient and donor age in deceased donor kidney transplantation in Japan Yuki Nakagawa, Japan |
| P-11.105 |
Outcome of dual kidney transplantation from marginal deceased kidney donor tarun kumar saha, India |
| P-11.106 |
Fully robotic live donor nephrectomy and open implantation in recipients: Does right or left kidney really matter? Amit Sharma, United States |
| P-11.110 |
Comparison of outcomes between open and robot assisted kidney transplant in paediatric population-initial results Anant Kumar, India |
| P-11.111 |
Non-simultaneous kidney exchange cycles in resource restricted countries without non-directed donation Hari Shankar Meshram, India |
| P-11.112 |
Donor and recipient outcomes of retroperitoneal laparoscopic donor nephrectomy in obese versus non obese donors: A prospective study NARESH KUMAR GARG, India |
| P-11.113 |
ATG- F (Grafalon) vs Thymoglobulin( r ATG ) as an induction agent in living donor renal transplant: A retrospective single centre experience Abhyudaysingh Rana, India |
| P-11.114 |
Comparison of clinical outcomes of living donor kidney transplantation in female recipients with birth history according to the relation to a donor Sung Shin, Korea |
| P-11.116 |
AI navigation system for living donor surgery: seven process classification of laparoscopic nephrectomy by deep learning Masato Nishihara, Japan |
| P-11.117 |
Long term results of living donor kidney transplantation Aydincan Akdur, Turkey |
| P-11.118 |
Longest single centre kidney exchange transplant chain of 10 donor-recipients pairs in India. AKASH GUPTA, India |
| P-11.119 |
Comparative analysis of donor and recipient outcomes of laparoscopic vs. open donor nephrectomy for allografts with multiple renal vessels Dinno Francis A Mendiola, Philippines |
| P-11.121 |
Outcome of renal transplantation in Alport's syndrome: A single-center experience. Harshit M Patel, India |
| P-11.131 |
The Korean Organ Transplantation Registry (KOTRY): First official kidney transplantation report Tai Yeon Koo, Korea |
| P-11.132 |
Association between IPV and chronic CNI toxicity with genetic analysis in kidney transplantation hyo kee kim, Korea |
| P-11.134 |
Risk factors for low graft function at 1 year after kidney transplantation CHANGHUN LEE, Korea |
| P-11.135 |
Artificial intelligence and machine learning to predict functional outcome of the arteriovenous fistulas - proof of concept model Muhammad A Khurram, United Kingdom |
| P-11.136 |
Identification of driven risk factors for HLA-DR in kidney transplantation Yunwei Zhang, Australia |
| P-11.137 |
Complete robotic-assisted kidney transplantation: A safe alternative to open approach Seung Duk Lee, United States |
| P-11.139 |
Renal allograft outcome from hypertensive donor: Comparison between living and deceased donor Yu Ho Lee, Korea |
| P-11.140 |
Comprehensive evaluation of echocardiographic changes after kidney transplantation and long-term outcomes Camilo Cortesi, United States |
| P-11.141 |
Intra-patient tacrolimus level variability in BK virus associated nephropathy Didem Turgut, Turkey |
| P-11.142 |
Intra-operative fluorescence angiography for renal graft perfusion assessment: An operative tool for post-transplant management GIUSEPPE IETTO, Italy |
| P-11.145 |
Analysis of intra-patient variability of tacrolimus in transplant patients with data mining Deniz DT Topcu, Turkey |
| P-11.146 |
Clinical benefits of coronary CT angiography in preventing cardiovascular complications among renal transplant recipients Si Youn Kim, Korea |
| P-11.147 |
Sodium/glucose cotransporter 2 inhibitors reduce microalbuminuria in diabetic renal transplant patients. Hyukyong Kwon, Korea |
| P-11.148 |
Effect of good dental care on oral inflammation, cytokines and chemokines levels in renal transplant patients: A randomized controlled study Sonia Mehrotra, India |
| P-11.149 |
Angiotensin receptor blockers provide better glomerular filtration rates than angiotensin converting enzyme inhibitors in kidney transplant recipients with proteinuria Burak Sayin, Turkey |
| P-11.150 |
Quality of life and associated factors of kidney transplant patients in Ethiopia Mekdim Siyoum, Ethiopia |
| P-11.151 |
Study of donors weight and sex correlation with recipients graft function in living related renal transplant Bhavin Satyanarayan Mandowara, India |
| P-11.152 |
Retroperitoneal viscum album extract injection in high drain output patient after renal transplantation Youngjun Park, Korea |
| P-11.153 |
Assessment of middle ear mechanics, internal ear acoustical emission measurements and hearing in renal transplant recipients Isilay Oz, Turkey |
| P-11.154 |
Survival and complications after multiple artery kidney transplantation Emre Karakaya, Turkey |
| P-11.155 |
How calcineurin inhibitor dosage and blood trough levels affect kidney allograft survival? Didem Turgut, Turkey |
| P-11.156 |
Why can’t I have a kidney transplant? Limitations to donate kidney or to have allograft Zeynep Kendi Çelebi, Turkey |
| P-11.157 |
The new crescentic incision: A good option for donor nephrectomy Ebru Hatice Ayvazoglu Soy, Turkey |
| P-11.159 |
Significance of rectal carriage screening for carbapenem resistance in a living donor renal transplantation setting in India Sneha Haridas Anupama, India |
| P-11.161 |
Blood pressure levels depending on the differences in the levels of salt intake in kidney transplant recipients HAJIME HIRANO, Japan |
| P-11.164 |
Long term outcome of asymptomatic kidney transplantation recipients with chronotropic incompetence - A perspective study over 8 Years Becky My Ma, Hong Kong |
| P-11.165 |
Evaluation of left ventricular geometric changes after kidney transplantation depending on allograft status Camilo Cortesi, United States |
| P-11.166 |
Clinical features and sensitization risk factors in patients awaiting kidney transplantation: A single center experience Zeynep Kendi Çelebi, Turkey |
| P-11.167 |
Prognostic value of early postoperative urinary protein to creatinine ratio after kidney transplantation Hye Ryoun Jang, Korea |
| P-11.168 |
Does the Kidney Donor Profile Index (KDPI) predict graft and patient survival in our population? Experience of a transplant center in Argentina Maria P. Dionisi, Argentina |
| P-11.169 |
Teriparatide in kidney transplant patients with severe hypocalcemia Luis Roberto Leon, Argentina |
| P-11.171 |
The relationship between skeletal and mandibular/alveolar bone quality after solid organ transplantation Bahar Füsun Oduncuoğlu, Turkey |
| P-11.173 |
Long term follow up of the orthopic renal transplant case with splenorenal anastomosis Ebru Hatice Ayvazoglu Soy, Turkey |
| P-11.174 |
Erythrocytosis post renal transplantation: A single centre study Mastakim Ahmed Mazumder, India |
| P-11.175 |
The change of frontal Qrs-t angle after renal transplantation in dialysis patients Mustafa Yilmaz, Turkey |
| P-11.176 |
Survival analysis in the presence of competing risks in kidney transplant Jessica J Pinto Ramirez PR, Colombia |
| P-11.177 |
Changes in ocular biometric parameters after renal transplantation Leyla Asena, Turkey |
| P-11.179 |
Cystinosis in pediatric renal transplant recipients: Case control study from Kuwait Osama Gheith, Kuwait |
| P-11.181 |
Paired kidney exchange transplantation experience in our center Ebru Hatice Ayvazoglu Soy, Turkey |
| P-11.183 |
Evaluation of dental and periodontal health of renal transplant and hemodialysis patients Bahar Füsun Oduncuoğlu, Turkey |
| P-11.184 |
Evolution of pediatric kidney transplantation: A single center experience Vasiliy Bogdanov, Russian Federation |
| P-11.185 |
Factors associated with post-transplant anemia in Colombian population with kidney transplant between 2007-2015: A case control study EYNER LOZANO, Colombia |
| P-11.187 |
The influence of immediate graft blood flow on early graft function Hsu-Han Wang, Taiwan |
| P-11.188 |
Is gastric sleeve surgery an optimal therapy for weight reduction post renal transplantation? Fatima AlKindi, United Arab Emirates |
| P-11.190 |
IL-10 promotes chronic BK-virus infection and HLA class I antibody formation in renal transplant recipients Rolf Weimer, Germany |
| P-11.192 |
A multidisciplinary approach in the management of enteric hyperoxaluria in kidney transplant candidates and recipients Matthew R D'Costa, United States |
| P-11.193 |
Renal graft parenchyma qualitative assessment through fluorescence angiography before kidney transplantation GIUSEPPE IETTO, Italy |
| P-11.194 |
Pretransplant dialysis modality and long-term outcomes in kidney transplantation recipients: A propensity score matching analysis Jin Hyuk Paek, Korea |
| P-11.195 |
Impact of body mass index and pre-sensitization in kidney transplant recipients on the long term allograft survival Yohan Park, Korea |
| P-11.200 |
Kidney transplantation in pediatric patients with lower urinary tract dysfunction Dorota Broniszczak-Czyszek, Poland |
| P-11.202 |
Preemptive kidney transplantation is associated with better graft survival compared with non‐preemptive transplantation. Woo Yeong Park, Korea |
| P-11.204 |
Kidney graft survival is better in patients with normal body mass index Leelo Järv, Estonia |
| Poster Session: Sex and Gender in Transplantation |
| P-15.06 |
Living donor kidney transplantation: Overcoming sex disparity in Japan Mikiko Yoshikawa, Japan |
| P-15.01 |
Pregnancy outcomes in 1164 female kidney transplant recipients Lisa Coscia, United States |
| P-15.04 |
Is altruistic (non-directed) living kidney donation a realm of Caucasian females? Experience from a single center in the United States Amit Sharma, United States |
